Tapewire

Nasdaq · USD

COLL

COLLEGIUM PHARMACEUTICAL, INC

Export transactions ↓
Tapewire entity
5169
SEC CIK
0001267565
Parsed reports
359

Last 12 months

Inside the activity.

0 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202503
Jan 202600
Feb 202600
Mar 202604
Apr 202600
May 202604
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 13, 2022 Filed Dec 14, 2022 23:06 UTC Exercise / conversionStock Option (Right to Purchase) · Derivative 7,904 $0.00 Strike: $14.57 $0.00
Disclosure

SEC source: 0001062993-22-023905 · form4.xml · derivative · entry 14

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,904 shares

Expires 2029-04-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: All of the 7,904 option shares are exercisable.

Read SEC document
December 13, 2022 Filed Dec 14, 2022 23:06 UTC Exercise / conversionStock Option (Right to Purchase) · Derivative 94,259 $0.00 Strike: $15.27 $0.00
Disclosure

SEC source: 0001062993-22-023905 · form4.xml · derivative · entry 13

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 94,259 shares

Expires 2027-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: All of the 94,259 option shares are exercisable.

Read SEC document
December 13, 2022 Filed Dec 14, 2022 23:06 UTC Exercise / conversionStock Option (Right to Purchase) · Derivative 59,524 $0.00 Strike: $14.90 $0.00
Disclosure

SEC source: 0001062993-22-023905 · form4.xml · derivative · entry 12

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 59,524 shares

Expires 2025-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: All of the 59,524 option shares are exercisable.

Read SEC document
December 13, 2022 Filed Dec 14, 2022 23:06 UTC SaleCommon Stock 161,687 $22.16 $3,582,983.92
Disclosure

SEC source: 0001062993-22-023905 · form4.xml · nonDerivative · entry 8

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,023

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).

Read SEC document
December 13, 2022 Filed Dec 14, 2022 23:06 UTC Exercise / conversionCommon Stock 7,904 $14.57 $115,161.28
Disclosure

SEC source: 0001062993-22-023905 · form4.xml · nonDerivative · entry 7

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 189,710

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 13, 2022 Filed Dec 14, 2022 23:06 UTC Exercise / conversionCommon Stock 94,259 $15.27 $1,439,334.93
Disclosure

SEC source: 0001062993-22-023905 · form4.xml · nonDerivative · entry 6

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,806

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 13, 2022 Filed Dec 14, 2022 23:06 UTC Exercise / conversionCommon Stock 59,524 $14.90 $886,907.60
Disclosure

SEC source: 0001062993-22-023905 · form4.xml · nonDerivative · entry 5

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,547

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 23:06 UTC Exercise / conversionStock Option (Right to Purchase) · Derivative 1,510 $0.00 Strike: $14.57 $0.00
Disclosure

SEC source: 0001062993-22-023905 · form4.xml · derivative · entry 11

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,510 shares

Expires 2029-04-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: All of the 1,510 option shares are exercisable.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 23:06 UTC Exercise / conversionStock Option (Right to Purchase)t to · Derivative 15,741 $0.00 Strike: $15.27 $0.00
Disclosure

SEC source: 0001062993-22-023905 · form4.xml · derivative · entry 10

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,741 shares

Expires 2027-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: All of the 15,741 option shares are exercisable.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 23:06 UTC Exercise / conversionStock Option (Right to Purchase) · Derivative 10,669 $0.00 Strike: $14.90 $0.00
Disclosure

SEC source: 0001062993-22-023905 · form4.xml · derivative · entry 9

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,669 shares

Expires 2025-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All of the 10,669 option shares are exercisable.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 23:06 UTC SaleCommon Stock 27,920 $22.01 $614,519.20
Disclosure

SEC source: 0001062993-22-023905 · form4.xml · nonDerivative · entry 4

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,023

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).

Read SEC document
December 12, 2022 Filed Dec 14, 2022 23:06 UTC Exercise / conversionCommon Stock 1,510 $14.57 $22,000.70
Disclosure

SEC source: 0001062993-22-023905 · form4.xml · nonDerivative · entry 3

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,943

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 23:06 UTC Exercise / conversionCommon Stock 15,741 $15.27 $240,365.07
Disclosure

SEC source: 0001062993-22-023905 · form4.xml · nonDerivative · entry 2

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,433

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 23:06 UTC Exercise / conversionCommon Stock 10,669 $14.90 $158,968.10
Disclosure

SEC source: 0001062993-22-023905 · form4.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,692

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 02, 2022 Filed Dec 5, 2022 23:16 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 54,400 $23.07 $1,255,008.00
Disclosure

SEC source: 0001062993-22-023357 · form4.xml · nonDerivative · entry 3

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,053

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.26, inclusive.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 23:16 UTC
Ciaffoni JosephDirector · President and CEO
Exercise / conversionStock Option (Right to Purchase) · Derivative 76,653 $0.00 Strike: $15.90 $0.00
Disclosure

SEC source: 0001062993-22-023357 · form4.xml · derivative · entry 4

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 76,653 shares

Expires 2029-01-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All of the 76,653 option shares are exercisable.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 23:16 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 76,653 $22.47 $1,722,392.91
Disclosure

SEC source: 0001062993-22-023357 · form4.xml · nonDerivative · entry 2

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 323,453

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

Read SEC document
December 01, 2022 Filed Dec 5, 2022 23:16 UTC
Ciaffoni JosephDirector · President and CEO
Exercise / conversionCommon Stock 76,653 $15.90 $1,218,782.70
Disclosure

SEC source: 0001062993-22-023357 · form4.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,106

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 28, 2022 Filed Nov 30, 2022 22:59 UTC
Ciaffoni JosephDirector · President and CEO
Exercise / conversionStock Option (Right to Purchase) · Derivative 43 $0.00 Strike: $15.90 $0.00
Disclosure

SEC source: 0001062993-22-022995 · form4.xml · derivative · entry 3

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 43 shares

Expires 2029-01-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: All of the 43 option shares are exercisable.

Read SEC document
November 28, 2022 Filed Nov 30, 2022 22:59 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 43 $22.00 $946.00
Disclosure

SEC source: 0001062993-22-022995 · form4.xml · nonDerivative · entry 2

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 323,453

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022.

Read SEC document
November 28, 2022 Filed Nov 30, 2022 22:59 UTC
Ciaffoni JosephDirector · President and CEO
Exercise / conversionCommon Stock 43 $15.90 $683.70
Disclosure

SEC source: 0001062993-22-022995 · form4.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 323,496

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 22, 2022 Filed Nov 25, 2022 23:11 UTC
Ciaffoni JosephDirector · President and CEO
Exercise / conversionStock Option (Right to Purchase) · Derivative 65 $0.00 Strike: $15.90 $0.00
Disclosure

SEC source: 0001062993-22-022779 · form4.xml · derivative · entry 3

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 65 shares

Expires 2029-01-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: All of the 65 option shares are exercisable.

Read SEC document
November 22, 2022 Filed Nov 25, 2022 23:11 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 65 $22.00 $1,430.00
Disclosure

SEC source: 0001062993-22-022779 · form4.xml · nonDerivative · entry 2

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 323,453

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022.

Read SEC document
November 22, 2022 Filed Nov 25, 2022 23:11 UTC
Ciaffoni JosephDirector · President and CEO
Exercise / conversionCommon Stock 65 $15.90 $1,033.50
Disclosure

SEC source: 0001062993-22-022779 · form4.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 323,518

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 18, 2022 Filed Nov 22, 2022 21:44 UTC
Ciaffoni JosephDirector · President and CEO
Exercise / conversionStock Option (Right to Purchase) · Derivative 1,989 $0.00 Strike: $15.90 $0.00
Disclosure

SEC source: 0001062993-22-022644 · form4.xml · derivative · entry 3

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,989 shares

Expires 2029-01-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All of the 1,989 option shares are exercisable.

Read SEC document
November 18, 2022 Filed Nov 22, 2022 21:44 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 1,989 $22.02 $43,797.78
Disclosure

SEC source: 0001062993-22-022644 · form4.xml · nonDerivative · entry 2

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 323,453

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).

Read SEC document
November 18, 2022 Filed Nov 22, 2022 21:44 UTC
Ciaffoni JosephDirector · President and CEO
Exercise / conversionCommon Stock 1,989 $15.90 $31,625.10
Disclosure

SEC source: 0001062993-22-022644 · form4.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 325,442

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 04, 2022 Filed Oct 6, 2022 16:23 UTC
Tupper ColleenEVP & Chief Financial Officer
SaleCommon Stock 4,350 $17.35 $75,472.50
Disclosure

SEC source: 0001062993-22-020614 · form4.xml · nonDerivative · entry 1

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,304

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.25 to $17.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).

Read SEC document
September 15, 2022 Filed Sep 16, 2022 16:22 UTC
Kuhlmann Shirley R.EVP and General Counsel
SaleCommon Stock 38,589 $18.07 $697,303.23
Disclosure

SEC source: 0001062993-22-019618 · form4.xml · nonDerivative · entry 1

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,495

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2022 and amended on August 15, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.91 to $18.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).

Read SEC document
August 11, 2022 Filed Aug 15, 2022 16:34 UTC
Kuhlmann Shirley R.EVP and General Counsel
SaleCommon Stock 300 $20.01 $6,003.00
Disclosure

SEC source: 0001062993-22-017994 · form4.xml · nonDerivative · entry 1

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,084

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).

Read SEC document
July 11, 2022 Filed Jul 13, 2022 20:50 UTC
Dreyer ScottEVP & Chief Commercial Officer
Tax withholdingCommon Stock 594 $17.48 $10,383.12
Disclosure

SEC source: 0001062993-22-016312 · form4.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,632

F1 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 20:35 UTC
Ciaffoni JosephDirector · President and CEO
Tax withholdingCommon Stock 1,394 $18.16 $25,315.04
Disclosure

SEC source: 0001062993-22-016068 · form4.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 323,453

F1 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
May 19, 2022 Filed May 23, 2022 21:53 UTC GrantCommon Stock 14,035 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-013316 · form4.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,023

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 19, 2023, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 19, 2022 Filed May 23, 2022 20:44 UTC GrantCommon Stock 14,035 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-013302 · form4.xml · nonDerivative · entry 1

Freund John Gordon · CIK 0001296771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,983

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 19, 2023, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 19, 2022 Filed May 23, 2022 20:55 UTC
SANTINI GINODirector
GrantCommon Stock 14,035 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-013309 · form4.xml · nonDerivative · entry 1

SANTINI GINO · CIK 0001276038 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,171

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 19, 2023, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 19, 2022 Filed May 23, 2022 21:42 UTC GrantCommon Stock 14,035 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-013313 · form4.xml · nonDerivative · entry 1

Melincoff Gwen A · CIK 0001614890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,983

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 19, 2023, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 19, 2022 Filed May 23, 2022 20:44 UTC GrantCommon Stock 14,035 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-013303 · form4.xml · nonDerivative · entry 1

McFarlane Neil F. · CIK 0001681098 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,880

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 19, 2023, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 19, 2022 Filed May 23, 2022 20:43 UTC GrantCommon Stock 14,035 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-013301 · form4.xml · nonDerivative · entry 1

Fallon John A. · CIK 0001560152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,358

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 19, 2023, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 19, 2022 Filed May 23, 2022 20:43 UTC GrantCommon Stock 14,035 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-013300 · form4.xml · nonDerivative · entry 1

BOHLIN GAREN G · CIK 0001254705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,983

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 19, 2023, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 19, 2022 Filed May 23, 2022 20:43 UTC GrantCommon Stock 14,035 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-013299 · form4.xml · nonDerivative · entry 1

Balice-Gordon Rita J. · CIK 0001825625 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,003

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 19, 2023, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
April 06, 2022 Filed Apr 8, 2022 21:12 UTC GrantCommon Stock 17,845 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-010000 · form4.xml · nonDerivative · entry 1

McFarlane Neil F. · CIK 0001681098 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,845

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on April 6, 2023, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
March 16, 2022 Filed Mar 18, 2022 16:03 UTC
Kuhlmann Shirley R.EVP and General Counsel
Tax withholdingCommon Stock 734 $18.99 $13,938.66
Disclosure

SEC source: 0001062993-22-008131 · form4.xml · nonDerivative · entry 1

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,384

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:14 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 11,011 $19.04 $209,649.44
Disclosure

SEC source: 0001062993-22-006644 · form4.xml · nonDerivative · entry 2

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 324,847

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021.

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.91 to $19.35, inclusive.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:14 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 65,083 $18.37 $1,195,574.71
Disclosure

SEC source: 0001062993-22-006644 · form4.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 335,858

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.90 to $18.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

Read SEC document
February 18, 2022 Filed Feb 28, 2022 21:24 UTC
Dreyer ScottEVP & Chief Commercial Officer
SaleCommon Stock 10,559 $21.61 $228,179.99
Disclosure

SEC source: 0001062993-22-005911 · form4.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,226

F1 · date: This Form 4 is being filed late due to an administrative error.

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2021 and amended on September 1, 2021.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.22 to $21.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3).

Read SEC document
February 10, 2022 Filed Feb 14, 2022 18:38 UTC
Tupper ColleenEVP & Chief Financial Officer
Tax withholdingCommon Stock 1,237 $17.63 $21,808.31
Disclosure

SEC source: 0001062993-22-004322 · form4.xml · nonDerivative · entry 4

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,654

F4 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 18:38 UTC
Tupper ColleenEVP & Chief Financial Officer
Tax withholdingCommon Stock 2,821 $17.63 $49,734.23
Disclosure

SEC source: 0001062993-22-004322 · form4.xml · nonDerivative · entry 3

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,891

F3 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 18:38 UTC
Tupper ColleenEVP & Chief Financial Officer
GrantCommon Stock 4,212 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-22-004322 · form4.xml · nonDerivative · entry 2

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,712

F2 · price: On February 10, 2022, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 4,212 performance share units granted in the issuer's prior fiscal year.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 18:38 UTC
Tupper ColleenEVP & Chief Financial Officer
GrantCommon Stock 45,500 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-004322 · form4.xml · nonDerivative · entry 1

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,500

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2023, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 18:37 UTC
Kuhlmann Shirley R.EVP and General Counsel
Tax withholdingCommon Stock 4,212 $17.63 $74,257.56
Disclosure

SEC source: 0001062993-22-004319 · form4.xml · nonDerivative · entry 4

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,118

F4 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.